Section 503A of the Federal Food, Drug, and Cosmetic Act allows licensed pharmacies to compound prescription medications when those medications are unavailable from the manufacturer (e.g., on FDAs shortage list) or when a patient needs a customized formulation that the commercial product cannot provide (such as a different concentration, an additive like B12, or an allergen-free form)
In this latest announcement, FDA reiterated its 2018 guidance while also clarifying its position on compounded GLP-1s combined with an additional API
Below youll find market size snapshots and exactly what to look for in a partner so you can plug in services fast, compliantly, and at scale
It acts on three hormone receptors involved in appetite, glucose handling, and energy balance: GLP-1, GIP, and glucagon receptors
This blog is intended to educate and inform and does not replace medical advice or nutrition therapy